3 Dividend Stocks That Are No-Brainer Buys Right Now
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Zacks Investment Research on MSN3d
Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know
Johnson & Johnson (JNJ) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.
24/7 Wall St.11d
Johnson & Johnson Just Paid Investors: Here's How Much They Got
Johnson & Johnson has rewarded shareholders with a quarterly dividend. As a Dividend King, it is the epitome of a steady and ...
Zacks Investment Research on MSN16d
Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It
Johnson & Johnson (JNJ) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.
Johnson & Johnson (JNJ) Receives a Buy from RBC Capital
In a report released yesterday, Shagun Singh Chadha from RBC Capital maintained a Buy rating on Johnson & Johnson (JNJ – Research Report), ...
Why Johnson & Johnson (JNJ) is the Best Pharma Stock to Buy According to Hedge Funds
We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...
Johnson & Johnson (NYSE:JNJ) Appoints Jessica Moore As Group CFO For Innovative Medicine
Johnson & Johnson (NYSE:JNJ) recently announced the appointment of Jessica Moore as the Group Chief Financial Officer for ...